SCHEMBL5813989

SCHEMBL5813989

COc1ccccc1C1CCN(Cc2ccc(C(=O)N3CCc4ccc(NC(=O)c5c(OC)cccc5OC)cc43)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
ATM Q13315 1/20 0.47
DRD4 P21917 2/20 0.47
DRD2 P14416 1/20 0.45
MAPK1 P28482 1/20 0.45
CHRM4 P08173 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AVPR1A P37288 1/20 0.44
MCHR1 Q99705 1/20 0.44
CCR5 P51681 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823977 0.85 MEN1 (0.53) MEN1KMT2AATMDRD4DRD2
SCHEMBL5814935 0.82 MAPK1 (0.62) ALDH1A1MEN1KMT2AATMDRD2
SCHEMBL5818308 0.80 MEN1 (0.53) MEN1KMT2AATMMAPK1CHRM4
SCHEMBL5820590 0.79 MEN1 (0.55) ALDH1A1MEN1KMT2AATMDRD4
SCHEMBL5899201 0.79 MEN1 (0.63) MEN1KMT2AATMDRD4DRD2
SCHEMBL5899197 0.77 MAPK1 (0.62) ALDH1A1MEN1KMT2AATMDRD4
SCHEMBL5805864 0.76 MEN1 (0.44) MEN1KMT2AATMCHRM4LMNA
SCHEMBL5820685 0.73 ADRA1D (0.55) ALDH1A1MEN1KMT2ADRD2LMNA
SCHEMBL5820519 0.72 HTR1A (0.54) MEN1KMT2ADRD2
SCHEMBL8557218 0.72 AVPR1A (0.60) ALDH1A1MAPK1MAPTSMN1; SMN2AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006088954-A1 DIHYDROINDOLYL METHANONES AS ALPHA 1A/1D ADRENORECEPTOR MODULATORS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY AND LOWER URINARY TRACT SYMPTOMS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-08-24 WO disclosed